Composition for PCR containing a polyethylene glycol-engrafted nano-sized graphene oxide
10633698 ยท 2020-04-28
Assignee
Inventors
Cpc classification
C08L71/08
CHEMISTRY; METALLURGY
C12Q2527/125
CHEMISTRY; METALLURGY
C08K3/042
CHEMISTRY; METALLURGY
C12Q2527/125
CHEMISTRY; METALLURGY
C08K3/042
CHEMISTRY; METALLURGY
International classification
C12P19/34
CHEMISTRY; METALLURGY
C08L71/08
CHEMISTRY; METALLURGY
Abstract
Disclosed are a composition for PCR including polyethylene glycol-engrafted nano-sized graphene oxide (PEG-nGO), the composition for PCR being capable of increasing the efficiency and specificity of PCR and shortening PCR time, and a PCR method using the same.
Claims
1. A composition for polymerase chain reaction (PCR), comprising 6-arm polyethylene glycol-engrafted nano-sized graphene oxide (PEG-nGO), wherein the PEG-nGO has a thickness of 4 to 5 nanometers (nm).
2. The composition for PCR according to claim 1, wherein the PEG-nGO is present at a concentration of 1 to 10 g/ml.
3. The composition for PCR according to claim 1, wherein each of a forward primer and a reverse primer is added to the composition for PCR at a concentration of 0.1 to 1.0 M.
4. The composition for PCR according to claim 1, wherein the PEG-nGO increases efficiency and specificity of PCR by inhibiting primer dimerization and nonspecific binding of amplified amplicons.
5. The composition for PCR according to claim 1, wherein the PEG-nGO promotes denaturation of double-stranded DNA in a sample to shorten PCR time.
6. A polymerase chain reaction (PCR) kit, comprising the composition according to claim 1.
7. A polymerase chain reaction (PCR) method, comprising: preparing a PCR sample by mixing a DNA template, dNTPs, a DNA polymerase, and forward and reverse primers for amplifying a target sequence with the composition for PCR according to claim 1; and performing PCR using the prepared PCR sample.
8. The PCR method according to claim 7, wherein, in the performing, PCR is selected from the group consisting of quantitative PCR (qPCR), real-time PCR, reverse transcription PCR (RT-PCR), solid phase PCR, competitive PCR, overlap-extension PCR, multiplex PCR, nested PCR, inverse PCR, ligation-mediated PCR, intersequence-specific PCR (ISSR), methylation-specific PCR (MSP), colony PCR, miniprimer PCR, nanoparticle-assisted PCR (nanoPCR), thermal asymmetric interlaced PCR (TAIL-PCR), touchdown PCR (step-down PCR), hot start PCR, in-silico PCR, allele-specific PCR, assembly PCR, asymmetric PCR, dial-out PCR, digital PCR (dPCR), and helicase-dependent amplification.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The above and other objects, features and advantages of the present invention will become more apparent to those of ordinary skill in the art by describing exemplary embodiments thereof in detail with reference to the accompanying drawings, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
(32) Exemplary embodiments of the present invention will be described in detail below with reference to the accompanying drawings. While the present invention is shown and described in connection with exemplary embodiments thereof, it will be apparent to those skilled in the art that various modifications can be made without departing from the spirit and scope of the present invention.
(33) As described above, PCR is a method of artificially amplifying DNA and is widely used in modern biotechnology and molecular biology. However, the efficiency and specificity of PCR may be reduced when PCR is not performed under optimal conditions. Therefore, studies are underway to increase the efficiency and specificity of PCR.
(34) Polyethylene glycol-engrafted nano-sized graphene oxide (PEG-nGO) included in the composition for PCR of the present invention functions as intracellular single-stranded binding proteins (SSBs) to bind to single-stranded DNA resulting from the denaturation of double-stranded DNA and to protect the same, and thus the PEG-nGO may improve the efficiency and specificity of PCR.
(35) Therefore, the present invention provides a composition for PCR including polyethylene glycol-engrafted nano-sized graphene oxide (PEG-nGO).
(36) In addition, the present invention provides a PCR kit including the composition for PCR.
(37) As used herein, the term PEG-nGO refers to modified graphene oxide in which PEG is conjugated to graphene oxide prepared in the form of a nano-sized particle. The PEG-nGO may be prepared by a method that can be understood by a person skilled in the art to have a structure shown in
(38) It is to be understood by those skilled in the art that the PEG-nGO serves as single-stranded binding proteins (SSBs) in a PCR sample. When DNA is amplified in the cell, SSBs bind to ssDNA separated from the template DNA and prevent ssDNA from being reannealed (
(39) The PEG-nGO of the present invention is preferably contained in a sample at a concentration of 1 to 10 g/ml. When the PEG-nGO is contained in a sample at a concentration of less than 1 g/ml, nonspecific DNA may be amplified because the PEG-nGO may not be effectively adsorbed to primers or ssDNA. When the PEG-nGO is contained in a sample at a concentration exceeding 10 g/ml, since the PEG-nGO is strongly adsorbed to DNA, there is a lack of primers and DNA templates used for DNA amplification, so that DNA amplification products may not be significantly obtained. In view of the present invention in which the PEG-nGO is used to increase the efficiency and specificity of PCR compared to conventional PCR techniques, the PEG-nGO is most preferably present at a concentration of 5 g/ml in a sample, without being limited thereto. The concentration of the PEG-nGO may be experimentally determined by a typical technician. That is, when PCR products are subjected to agarose gel electrophoresis and a single DNA band is observed, it may be judged that the concentration of the PEG-nGO used in PCR is appropriate.
(40) As used herein, a composition for PCR may additionally include PCR elements required for general PCR, such as a DNA polymerase, dNTPs, a DNA template, and primers. The primer may be synthesized by a conventional method to obtain an amplification product by complementarily binding to target DNA to be amplified. The primer refers to a single-stranded oligonucleotide complementary to a nucleic acid sequence to be replicated and may serve as a starting point for synthesis of a primer-mediated extension product. The length and sequence of the primer should be determined to be suitable for synthesis of an extended product. The specific length and sequence of the primer depend on primer usage conditions such as temperature and ionic strength, as well as the complexity of target DNA or RNA.
(41) When performing PCR using the composition for PCR of the present invention, both forward and reverse primers are preferably contained in a PCR sample. In this case, each forward and reverse primer is preferably present at a concentration of 0.1 to 1.0 M, without being limited thereto. The concentration of the primers may be experimentally determined by a typical technician. That is, when PCR products are subjected to agarose gel electrophoresis and a single DNA band is observed, it may be judged that the concentration of the primers used in PCR is appropriate.
(42) In a specific embodiment of the present invention, the present inventors first prepared PEG-nGO to confirm whether PCR efficiency was increased when the PEG-nGO was added. The prepared PEG-nGO was found to be thicker than GO and nGO due to PEG bonding (
(43) In addition, when PCR was performed on a PCR sample containing GO, nGO or PEG-nGO, a specific PCR product was not observed in a sample containing the GO or the nGO, whereas a specific PCR product was observed in a sample containing the PEG-nGO (
(44) In addition, the present inventors confirmed the optimal concentration of the PEG-nGO for increasing the efficiency and specificity of PCR. As a result, the optimal concentration of the PEG-nGO was determined to be 5 g/ml (
(45) In addition, the present inventors predicted that the PEG-nGO inhibited dimerization of primers abundant in a sample in the initial stage of PCR. Thus, the effect of the PEG-nGO on PCR efficiency depending on the concentration of primers was confirmed. As a result, when performing conventional PCR by adding the PEG-nGO, the optimal concentration of the PEG-nGO was 5 g/ml. At this concentration, the PEG-nGO was effectively adsorbed to primers and inhibited the generation of primer dimers (
(46) In addition, the present inventors confirmed whether smearing of a nonspecific DNA band was reduced depending on the presence or absence of the PEG-nGO even at a low annealing temperature. As a result, the PEG-nGO was adsorbed to ssDNA abundant in a PCR sample, so that the concentration of ssDNA was appropriately maintained while temperature was changed, thereby reducing erroneous binding between primers and DNA templates (
(47) In addition, the present inventors predicted that the PEG-nGO increased the specificity and efficiency of PCR by inhibiting reannealing of amplified DNA during the annealing step and promoted DNA melting during the denaturation step. As a result of conducting experiments to confirm the above prediction, it was confirmed that the PEG-nGO effectively inhibited the nonspecific reannealing of amplified DNA amplicons (
(48) In addition, the present inventors confirmed whether PCR using the PEG-nGO was affected by the sequence size of target DNA. As a result, it was confirmed that, when the PEG-nGO was added to a PCR sample according to optimal conditions, the specificity and efficiency of PCR were improved regardless of the sequence size of the target DNA (
(49) The PEG-nGO of the present invention acts as intracellular SSBs, and may bind to single-stranded DNA resulting from the denaturation of double-stranded DNA and may protect the single-stranded DNA. Since the PEG-nGO is adsorbed to primers abundant in the early stage of PCR, formation of primer dimers and nonspecific annealing between the primers and DNA templates may be reduced. In addition, in the late stage of PCR, in which amplified PCR products are accumulated, the PEG-nGO effectively binds to single-stranded DNA resulting from the denaturation of double-stranded DNA and may inhibit reannealing of amplified ssDNA, thereby promoting annealing between primers and DNA templates.
(50) Therefore, the PEG-nGO of the present invention i) may increase the efficiency and specificity of PCR even in PCR proceeding in multiple rounds; ii) may improve PCR efficiency by inhibiting formation of primer dimers in a sample and improper annealing of primers at low annealing temperatures; iii) may reduce the time required for the denaturation step during PCR by promoting separation of double-stranded DNA templates, thereby effectively providing DNA templates and reducing the overall PCR run time; and iv) may also improve PCR efficiency in PCR for amplifying genes having various sizes. Thus, when using the PEG-nGO, the disadvantages that may occur in conventional PCR techniques may be overcome, and the efficiency and specificity of PCR may be improved.
(51) In addition, the present invention provides a method of performing PCR, the method including the following steps i) and ii):
(52) i) a step of preparing a PCR sample by mixing a DNA template, dNTPs, a DNA polymerase, and forward and reverse primers for amplifying a target sequence with the composition for PCR of the present invention including PEG-nGO; and
(53) ii) a step of performing PCR using the prepared PCR sample.
(54) The PEG-nGO of step i) is preferably present at a concentration of 1 to 10 g/ml. When the PEG-nGO is contained in a sample at a concentration of less than 1 g/ml, nonspecific DNA may be amplified because the PEG-nGO may not be effectively adsorbed to primers or ssDNA. When the PEG-nGO is contained in a sample at a concentration exceeding 10 g/ml, since the PEG-nGO is strongly adsorbed to DNA, there is a lack of primers and DNA templates used for DNA amplification, so that DNA amplification products may not be significantly obtained. In view of the present invention in which the PEG-nGO is used to increase the efficiency and specificity of PCR compared to conventional PCR techniques, the PEG-nGO is most preferably present at a concentration of 5 g/ml in a sample, without being limited thereto. The concentration of the PEG-nGO may be experimentally determined by a typical technician. That is, when PCR products are subjected to agarose gel electrophoresis and a single DNA band is observed, it may be judged that the concentration of the PEG-nGO used in PCR is appropriate.
(55) Each forward and reverse primer of step i) is present at a concentration of 0.1 to 1.0 M, without being limited thereto, the concentration of the primers may be experimentally determined by a typical technician. That is, when PCR products are subjected to agarose gel electrophoresis and a single DNA band is observed, it may be judged that the concentration of the primers used in PCR is appropriate.
(56) In step ii), PCR may be selected from the group consisting of quantitative PCR (qPCR), real-time PCR, reverse transcription PCR (RT-PCR), solid phase PCR, competitive PCR, overlap-extension PCR, multiplex PCR, nested PCR, inverse PCR, ligation-mediated PCR, intersequence-specific PCR (ISSR), methylation-specific PCR (MSP), colony PCR, miniprimer PCR, nanoparticle-assisted PCR (nanoPCR), thermal asymmetric interlaced PCR (TAIL-PCR), touchdown PCR (step-down PCR), hot start PCR, in-silico PCR, allele-specific PCR, assembly PCR, asymmetric PCR, dial-out PCR, digital PCR (dPCR), and helicase-dependent amplification. The PCR method of the present invention may be applied without limitation, when PCR is performed by a typical technician to artificially amplify DNA.
(57) Hereinafter, the present invention will be described in more detail with reference to Examples. It will be apparent to those skilled in the art that these embodiments are for illustrative purposes only and that the scope of the present invention is not construed as being limited by these examples.
EXAMPLES
Example 1. Preparation of Polyethylene Glycol-Engrafted Nano-Sized Graphene Oxide (PEG-nGO)
(58) PEG-nGO for use in the present invention was prepared.
(59) Specifically, GO (HCGO-W-175) was purchased from Graphene Laboratories Co. (Ronkonkoma, N.Y., USA). A 6-arm polyethylene glycol amine (15 kDa) was purchased from SunBio Co. (Seoul, Korea). The GO having a concentration of 5 mg/ml was diluted to a concentration of 2 mg/ml, and then subjected to tip ultrasonication on ice for 5 hours to prepare GO that is broken up in nano units (i.e., nano-sized GO, nGO). Then, for PEGylation, 1.2 g of NaOH and 1.0 g of chloroacetic acid were added to 5 ml of the prepared nGO suspension, followed by ultrasonication for 4.5 hours. This allows the OH of the surface of the nGO to be converted to a COOH group through conjugation of an acetic acid moiety to obtain nGO (HOOC-nGO) having a carboxyl group bonded thereto. The obtained HOOC-nGO solution was repeatedly rinsed with distilled water for neutralization and then filtered through a 0.2 m filter membrane (Millipore, USA) to obtain purified HOOC-nGO. The purified HOOC-nGO was diluted with water until an optical density was 0.4 at 808 nm. Then, 2 mg/ml of the 6-arm PEG-amine solution was added to the diluted HOOC-nGO solution and they were mixed using ultrasonic waves for 5 minutes. Thereafter, N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride was added to the mixed solution so that the final concentration was 5 mM, and the mixture was stirred for 12 hours. The mixing reaction was terminated by addition of 50 mM mercaptoethanol. The obtained mixture was diluted in distilled water for 12 hours, centrifuged at 10,000g for 1 hour in phosphate-buffered saline to obtain a supernatant containing PEG-nGO, and the supernatant was stored at 4 C.
(60) The prepared graphene materials (GO, nGO, and PEG-nGO) were analyzed using atomic force microscopy (XE-100 AFM; ParkSystems, Seoul, Korea) and Fourier transform infrared spectroscopy (Tensor 27 FT-IR spectrometer; Bruker, Billerica, Mass., USA). As a result, as shown in
Example 2. Evaluation of PCR Efficiency in Samples Containing PEG-nGO
(61) <2-1> Evaluation of Effect of Addition of GO, nGO or PEG-nGO on PCR Efficiency
(62) To confirm whether PCR efficiency was increased when the PEG-nGO of the present invention was added, PCR amplification was performed on a PCR sample to which GO, nGO or the PEG-nGO was added.
(63) Specifically, first, intracellular RNA was extracted from a human leukemia cell line, K562 (purchased from ATCC) using a TRIzol reagent (Invitrogen Co., USA). 1 g of the extracted RNA was used as a template, and reverse transcription-polymerase chain reaction (RT-PCR) was performed using a PrimeScript 1st strand cDNA synthesis kit (TaKaRa Bio Co., Shiga, Japan) to obtain cDNA. The cDNA complementary to cell-derived RNA was stored at 20 C. for future use.
(64) The cDNA was used as a DNA template, and GAPDH (110 bp) was selected as a target sequence to be amplified. Primers for amplifying GAPDH were synthesized and purified by Cosmo Genetech Co. (Seoul, Korea). A forward primer is represented by SEQ ID NO: 1 (5-TTG TTG CCA TCA ATGACC CCT TCA TTG ACC-3), and a reverse primer is represented by SEQ ID NO: 2 (5-CTT CCC GTT CTC AGC CTT GACGGT G-3). A PCR sample was prepared by mixing 3 l (150 ng) of cDNA, 0.083 U/l Ex Taq polymerase (TaKaRa Bio Co., Shiga, Japan), 0.25 mM deoxynucleotides (dNTPs), 1Ex Taq buffer, 100 nM of each PCR primer, and PEG-nGO (at a concentration of 1, 5 or 10 g/ml), and the total volume of the PCR sample was adjusted to 30 l. PCR amplification was performed according to the following repetition program: after pre-denaturation at 95 C. for 5 minutes, a reaction cycle composed of a denaturation step at 95 C. for 30 seconds, an annealing step at 60 C. for 30 seconds, and an extension step at 72 C. for 1 minute was repeated 30 times, and a final step was conducted at 72 C. for 8 minutes. The PCR products were separated by agarose gel electrophoresis and identified as DNA bands stained with EtBR. The intensity of the DNA band was quantitatively analyzed using ImageJ software (http://rsb.info.nih.gov/ij/index.html).
(65) As a result, as shown in
(66) <2-2> Evaluation of Effect of PEG and nGO Binding on PCR Efficiency in Sample
(67) The above results show that PCR efficiency is increased when the PEG-nGO is added compared to when the GO or the nGO is added. It was further confirmed that this effect was due to the PEG-nGO, a conjugated form of PEG and the nGO.
(68) Specifically, when PCR samples were prepared, the PEG-nGO was mixed at a concentration of 1, 5 or 10 g/ml (PEG-nGO) or each of PEG and nGO was mixed at a concentration of 1, 5 or 10 g/ml (PEG+nGO). PCR for amplification of GAPDH cDNA was performed in the same manner as in <2-1> above.
(69) As a result, as shown in
(70) <2-3> Confirmation of Affinity Between PEG-nGO and PCR Elements
(71) To further clarify a mechanism by which PCR efficiency is increased when the PEG-nGO is included in a PCR sample, binding affinity between the PEG-nGO and PCR elements, such as ssDNA and a DNA polymerase, was confirmed.
(72) Specifically, first, to confirm binding affinity between nGO materials (GO, nGO or PEG-nGO) and ssDNA, 10 nM fluorescein isothiocyanate (FITP)-labeled 95 mer ssDNA was mixed with various concentrations of the GO, the nGO or the PEG-nGO (0, 1, 5, 10, 15, 20, 30, 40, and 50 g/ml) and heated at 95 C. for 10 minutes. Thereafter, the reaction mixtures were transferred to a 96-well plate, and fluorescence intensity was measured at wavelengths of .sub.ex=485 nm and .sub.em=535 nm using a multilabel plate reader (VICTOR X3; PerkinElmer, Waltham, Mass., USA). Fluorescence intensity was calculated by the equation (F.sub.maxF)/(F.sub.maxF.sub.min) (F.sub.max and F.sub.min represent the maximum and minimum absorbance values, respectively). The binding affinity Kd value indicates the affinity between ssDNA and the graphene materials, and was calculated by applying the fluorescence intensity to the hyperbolic equation.
(73) Next, to confirm binding affinity between nGO materials (GO, nGO or PEG-nGO) and a DNA polymerase, Taq DNA polymerase (0.2 g/l) was mixed with various concentrations of the GO, the nGO or the PEG-nGO (0, 5, 10 and 20 g/ml) and heated at 95 C. for 10 minutes. The heated mixtures were loaded on an 8% SDS-PAGE gel and analysis was performed.
(74) As a result, as shown in
Example 3. Establishment of Optimal Conditions for PEG-nGO Addition to Increase PCR Efficiency and Specificity
(75) <3-1> Determination of Optimal Concentration of PEG-nGO
(76) To determine the optimal concentration of the PEG-nGO for increasing PCR specificity, PCR amplification was performed on samples containing various concentrations of the PEG-nGO.
(77) Specifically, a PCR sample was prepared by mixing 3 l (150 ng) of cDNA, 0.083 U/l Ex Taq polymerase, 0.25 mM deoxynucleotides (dNTPs), 1Ex Taq buffer, and 100 nM of each PCR primer, and various concentrations of the PEG-nGO (0, 0.1, 1, 5, 10, 20, and 50 g/ml) were added to the sample, respectively, and the total volume of the sample was adjusted to 30 l. The prepared PCR samples were subjected to PCR under the same conditions as Example <2-1> to amplify GAPDH cDNA, and electrophoresis was performed to detect DNA bands.
(78) As a result, as shown in
(79) <3-2> Evaluation of Effect of PEG-nGO Addition on PCR Efficiency in Consecutive Rounds of PCR
(80) A large number of nonspecific amplicons may be generated due to nonspecific binding of primers or the like during PCR. To solve this problem, various PCR techniques such as nested PCR may be used. In nested PCR, PCR amplification is performed in two separate steps. In the first step, a primer set for amplifying a broad range including a target sequence on a DNA template is used, and in the second step, primer sequences for amplifying only the target sequence are generally used as an inner primer set. Thus, nested PCR has a disadvantage that gene amplification reaction should be performed in two steps using different primer sets.
(81) To confirm the effect of the PEG-nGO in increasing the efficiency and specificity of the PCR proceeding in a continuous process, in the first and second steps, PCR was performed depending on whether the PEG-nGO was added. Specifically, a PCR sample with or without 5 g/ml of the PEG-nGO was prepared, and the first round of PCR was performed. The PCR products obtained from the first round of PCR were subjected to a serial dilution (10.sup.0 to 10.sup.6 times), and the second round of PCR was performed on the diluted PCR products. After completion of PCR, electrophoresis was performed to identify DNA bands.
(82) As a result, as shown in
(83) In addition, to determine whether the efficiency of DNA amplification may be increased when consecutive rounds of PCR using the same PCR primers was performed in the presence of the PEG-nGO, consecutive rounds of PCR was performed on samples containing the PEG-nGO, and amplification of target DNA was monitored. At this time, PCR was repeatedly performed for a total of five rounds. After each step, PCR products were directly used in the next step as a DNA template without dilution.
(84) As a result, as shown in
(85) Since it is necessary to add the PEG-nGO in the fifth round, in the first to fourth rounds, PCR was performed under the same conditions, and the fifth round of PCR was performed under conditions in which the concentration of the PEG-nGO was increased (0, 5, 10 or 15 g/ml).
(86) As a result, as shown in
Example 4. Evaluation of Effect of Adsorption Between PEG-nGO and Primers on Efficiency and Specificity of PCR
(87) <4-1> Evaluation of Effect of PEG-nGO on PCR Efficiency at Various Primer Concentrations
(88) To determine whether the optimal concentration of the PEG-nGO varies with an initial primer concentration, PCR was performed by adding PEG-nGO at a concentration of 5 g/ml and adding primers at various concentrations (0.05, 0.1, 0.5 or 1.0 M).
(89) As a result, as shown in
(90) These results indicate that it is advantageous to perform PCR by adding the PEG-nGO at an optimal concentration (5 g/ml) that may be selected when performing conventional PCR. This indicates that the PEG-nGO may increase the specificity of DNA amplification in a broad range of primer concentrations, including a low concentration at which the PEG-nGO is not required.
(91) <4-2> Determination of Adsorption Between PEG-nGO and Primers in Sample not Containing DNA Template
(92) In conventional PCR methods, non-specific PCR products may be generated by interaction between primers, resulting in primer dimerization. Primer dimers may be generated when primer concentration is high or the 3-ends of forward and reverse primers are complementary to each other. Based on the fact that the PEG-nGO is adsorbed to ssDNA in a concentration-dependent manner, as shown in Example <2-3> (
(93) As a result, as shown in
Example 5. Evaluation of Effect of PEG-nGO on Efficiency and Specificity of PCR at Various Annealing Temperatures
(94) Since primers may easily bind to DNA template strands at low temperatures, the yield of PCR products may be increased, but the specificity of DNA amplification may be reduced. Thus, to confirm whether a smearing phenomenon due to nonspecifically amplified DNA may be reduced depending on the presence or absence of the PEG-nGO even at low annealing temperatures, DNA was amplified under PCR conditions in which an annealing temperature was set at 30 to 50 C.
(95) As a result, as shown in
Example 6. Evaluation of Effect of PEG-nGO on Reannealing of DNA Templates Denatured by Temperature
(96) The accuracy of DNA replication is a very important factor in DNA amplification. While DNA is amplified in the cells, double-stranded DNA (dsDNA) is separated by a DNA helicase, and various SSBs bind to the separated ssDNA. At this time, SSBs inhibit reannealing of ssDNA, thereby ensuring high accuracy and efficiency in DNA replication. In the present invention, the PEG-nGO was expected to play a role similar to SSBs. Thus, the present inventors expected that the PEG-nGO may increase PCR specificity and efficiency by inhibiting reannealing of amplified DNA during the annealing step, and may promote DNA melting during the denaturation step.
(97) <6-1> Determine Whether PEG-nGO Protects ssDNA in Consecutive Rounds of PCR
(98) To prove this hypothesis, PCR samples with or without 1.0 M of each primer were prepared and consecutive rounds of PCR were performed. At this time, no PEG-nGO was added in the first PCR round, and 3, 5 or 10 g/ml of PEG-nGO was added in the second PCR round.
(99) As a result, as shown in
(100) <6-2> Evaluation of Effect of PEG-nGO on DNA Melting
(101) To determine the effect of temperature on the PEG-nGO in increasing PCR efficiency, the effect of the PEG-nGO on the melting temperature (Tm) of PCR products was confirmed by measuring the amount of dsDNA present in the bound state without ssDNA denaturation during PCR. 1SYBR Green I (Invitrogen Co., Carlsbad, Calif., USA), 5 l of 0.16 g/l 110-bp GAPDH amplicons, and the PEG-nGO (0, 1, 3, or 5 g/ml) were mixed, and the final volume was adjusted to 20 l. Thereafter, using a real-time gene amplifier (Rotor-Gene Q; Qiagen, Hilden, Germany), fluorescence changes were measured at wavelengths of .sub.ex=470 nm and .sub.em=510 nm at every 0.5 C. rise while raising the temperature from 25 to 99 C. Based on the obtained results, melting temperatures (Tm) were determined.
(102) As a result, the melting curve of amplified dsDNA is shown in
(103) <6-3> Evaluation of Effect of PEG-nGO on Dissociation of Amplified dsDNA
(104) To confirm whether the PEG-nGO may facilitate dissociation of PCR-amplified dsDNA, a PCR cycle composed of three steps (denaturation, annealing, and extension steps) was shortened to two steps, that is, a PCR cycle composed of a first step at 95 C. for 1 second and a second step at 60 C. for 15 seconds was repeated 30 times. As a control group (C), a sample not containing the PEG-nGO was used. In this case, a PCR cycle composed of a first step at 95 C. for 30 seconds, a second step at 60 C. for 30 seconds, and a third step at 72 C. for 1 minute was repeated 30 times.
(105) As a result, as shown in
Example 7. Evaluation of Effect of PEG-nGO on Efficiency and Specificity of PCR Depending on Lengths of Target DNA
(106) To determine whether the PEG-nGO may increase PCR specificity when target DNA having various lengths was amplified, PCR was performed on target DNA sequences having various lengths as a DNA template. PCR to obtain DNA amplicons of various sizes was performed using pET22b(+) (Merck Millipore, Darmstadt, Germany), a linear plasmid DNA, as a template, and appropriate primers (shown in Table S1 and
(107) TABLE-US-00001 TABLE1 Primersequencesusedtoamplifytargetsequenceshavingvariousamplicon sizes Amplicon Primername size(bp) SEQIDNO Sequence Forwardprimer SEQIDNO:3 5-GTGTCTCTTATCAGACCGTT-3 Reverseprimerl 102 SEQIDNO:4 5-TGTAATTCAGCTCCGCCAT-3 Reverseprimer2 198 SEQIDNO:5 5-CAATTTGCGACGGCGCG-3 Reverseprimer3 401 SEQIDNO:6 5-AAATAACGCCGGAACATTAGT-3 Reverseprimer4 805 SEQIDNO:7 5-TAACATGAGCTGTCTTCGGT-3 Reverseprimer5 1600 SEQIDNO:8 5-ACATAATGGTGCAGGGCG-3
(108) As a result, as shown in
(109) Therefore, the present invention provides a composition for PCR including PEG-nGO. The PEG-nGO included in the composition for PCR of the present invention functions as intracellular single-stranded binding proteins (SSBs) to bind to single-stranded DNA resulting from the denaturation of double-stranded DNA and to protect the same. The PEG-nGO can bind to single-stranded DNA and protect the same. Thus, the PEG-nGO is adsorbed to primers abundant in the early stage of PCR, and can reduce formation of primer dimers and nonspecific annealing between the primers and DNA templates. In addition, in the late stage of PCR, in which amplified PCR products are accumulated, the PEG-nGO effectively binds to single-stranded DNA resulting from denaturation of double-stranded DNA and can inhibit reannealing of amplified ssDNA, thereby promoting annealing between primers and DNA templates.
(110) Therefore, the PEG-nGO of the present invention i) can increase the efficiency and specificity of PCR even in PCR proceeding in multiple rounds; ii) can improve PCR efficiency by inhibiting formation of primer dimers in a sample and improper annealing of primers at low annealing temperatures; iii) can reduce the time required for the denaturation step during PCR by promoting separation of double-stranded DNA templates, thereby effectively providing DNA templates and reducing the overall PCR run time; and iv) can also improve PCR efficiency in PCR for amplifying genes having various sizes. Thus, when using the PEG-nGO, the disadvantages that can occur in conventional PCR techniques can be overcome, and the efficiency and specificity of PCR can be improved.